Hypofractionated Radiation increases the Expression of the Immune Checkpoint-Molecule HVEM on TS/A Breast Cancer- and B16 Melanoma Cells (2021) Flohr AS, Grün A, Fietkau R, Rückert M, Gaipl U Conference contribution The OAR Turing-Test Study: A blinded Comparison of expert-Based Organ at Risk Creation and three commercial Auto-Segmentation Solutions (2021) Putz F, Lamrani A, Weissmann T, Mansoorian S, Frey B, Bert C, Fietkau R Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Effect of the AMPA Receptor Inhibitor Perampanel in Combination Therapy with ionizing Radiation on Glioblastoma Cells and Fibroblasts (2021) Knabe A, Stritzelberger J, Fietkau R, Distel L Conference contribution Influence of CDK4/6 Inhibitors and Ionizing Radiation on Senescence in Breast Cancer Cells (2021) Quarz L, Jost T, Fietkau R, Distel L Conference contribution Vulnerabilitäten bei Radiomics: Warum die populärste Radiomics-Signatur unbemerkt das Tumorvolumen gemessen hat (2021) Putz F, Fietkau R Journal article, Editorial Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group (2021) Ostheimer C, Maeurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, et al. Journal article